Hypothesis

Oral administration of a defined lysate from lytic bacteriophages that infect common gut commensals releases muropeptide fragments capable of re‑programming aged immune cells. These peptidoglycan derivatives act as selective NOD2 agonists, triggering autophagy‑dependent clearance of senescent immune cells (particularly p16^INK4a^+ CD8^+ T cells and NLRP3‑activated macrophages) while simultaneously suppressing inflammasome signaling. By directly targeting the mechanistic core of immunosenescence—failed senescent cell clearance and chronic inflammasome activation—the phage‑lysate intervention should slow, and possibly reverse, immune‑driven neuroinflammation and cognitive decline.

Mechanistic Rationale

• Muropeptide‑NOD2 signaling → NF‑κB‑independent IRF4 activation → upregulation of ATG5/LC3‑II autophagic flux in phagocytes.
• Enhanced autophagy promotes lysosomal degradation of senescent cell‑associated SASP components and facilitates phagocytic removal of p16^INK4a^+ immune neighbors (“immunosenolytic” activity).
• Concurrent inhibition of NLRP3 via increased intracellular potassium efflux and mito‑ROS scavenging, lowering IL‑1β release.
• Microbiota‑gut‑brain axis: reduced systemic inflammasome activity diminishes circulating IL‑1β and TNF‑α, limiting microglial priming and preserving hippocampal synaptic plasticity.

These steps extend the argument that the immune system is a driver of aging by providing a concrete microbial metabolite that can re‑educate the immune compartment rather than merely dampening inflammation.

Testable Predictions

1. Aged mice (20‑month) receiving daily gavage of the phage lysate for 8 weeks will show a ≥30 % reduction in circulating p16^INK4a^+ CD8^+ T cells (flow cytometry) compared with vehicle controls.
2. The same cohort will exhibit decreased caspase‑1 activity and IL‑1β levels in peritoneal macrophages, indicating NLRP3 inflammasome suppression.
3. Cognitive performance in the Morris water maze will improve by ≥15 % (reduced escape latency) correlating with the magnitude of senescent immune cell depletion.
4. Germ‑free mice colonized with the phage‑lysate‑treated microbiota will recapitulate the immunosenolytic effect, confirming a microbiota‑mediated mechanism.

Falsifiability

If phage‑lysate treatment fails to lower p16^INK4a^+ immune cell frequencies or inflammasome markers, or if cognitive benefits occur without concomitant immunosenescent changes, the central claim—that immune senescence is the primary conduit for microbiome‑driven neuroprotection—would be falsified.

References (adapted from seed)

• NLRP3 inflammasome causally links systemic low‑grade inflammation to functional decline in aging 1
• Telomere‑driven cellular senescence accelerates neuroinflammation and neurodegeneration 2
• Bifidobacterium breve A1 improves RBANS scores in MCI 3
• Senescent cell accumulation with age due to increased production and decreased removal 4
• Gut inflammation linked to AD pathology pre‑symptomatically 5

Key innovation: using phage‑derived muropeptides as precision immunosenolytic agents, with p16^INK4a^+ immune cells and inflammasome activity as both strain‑selection biomarkers and primary trial endpoints.